CNXC CNXC
Company Profile ↓Company Overview
CNXC (CNXC) is a publicly traded company listed on with a market capitalization of $1.83B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 13.1% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Nov 2025 Revenue of $9.83B (+2.2% YoY); net profit $-1.28B.
- Trailing 12 Months Year-on-year growth — revenue +2.1%, earnings -609.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.05% |
| 1 Year: | 2.15% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -609.09% |
Stock Price Performance
| 1 Year: | -40.61% |
| 6 Months: | -28.02% |
| 3 Months: | +11.09% |
| 1 Month: | +15.95% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)56.94 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.1% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 52.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Feb 2020 | May 2020 | Aug 2020 | Feb 2021 | May 2021 | Aug 2021 | Feb 2022 | May 2022 | Aug 2022 | Feb 2023 | May 2023 | Aug 2023 | Feb 2024 | May 2024 | Aug 2024 | Feb 2025 | May 2025 | Aug 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.07B | 1.16B | 1.35B | 1.37B | 1.40B | 1.54B | 1.57B | 1.58B | 1.64B | 1.61B | 1.63B | 2.40B | 2.38B | 2.39B | 2.37B | 2.42B | 2.48B | 2.50B | 2.46B |
| Gross Profit | 445.19M | 345.17M | 412.53M | 486.05M | 482.73M | 481.34M | 538.13M | 558.92M | 566.85M | 581.16M | 580.23M | 593.69M | 856.53M | 857.57M | 864.19M | 855.90M | 848.15M | 855.01M | 849.66M | 823.35M |
| Operating Income | 88.21M | 23.58M | 76.76M | 134.89M | 128.22M | 151.38M | 147.75M | 156.91M | 157.54M | 156.05M | 162.57M | 162.27M | 148.44M | 150.17M | 153.24M | 168.87M | 148.34M | 146.98M | 118.56M | 95.42M |
| Net Income | 52.32M | 2.47M | 45.40M | 88.81M | 82.90M | 109.75M | 110.27M | 113.14M | 106.69M | 87.87M | 78.85M | 77.64M | 52.10M | 66.83M | 16.63M | 70.26M | 42.09M | 88.11M | 21.59M | 55.28M |
| Diluted EPS | 1.01 | 0.05 | 0.88 | 1.69 | 1.57 | 2.08 | 2.09 | 2.14 | 2.04 | 1.68 | 1.51 | 1.49 | 0.76 | 0.98 | 0.25 | 1.04 | 0.63 | 1.34 | 0.33 | 0.86 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.71B | 4.72B | 5.59B | 6.32B | 7.11B | 9.62B | 9.83B |
| Gross Profit | 1.75B | 1.66B | 1.97B | 2.26B | 2.58B | 3.45B | 3.44B |
| Operating Income | 294.33M | 308.76M | 572.40M | 640.19M | 661.33M | 596.39M | -918.18M |
| Net Income | 117.16M | 164.81M | 405.58M | 435.05M | 313.84M | 251.22M | -1.28B |
| Diluted EPS | 2.27 | 3.19 | 7.70 | 8.28 | 5.70 | 3.71 | -20.36 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 5.18B | - | 6.67B | 12.49B | 11.99B | 10.76B |
| Current Assets | - | - | - | - | 1.75B | 2.86B | 2.84B | 3.08B |
| Cash & Equivalents | - | - | 152.66M | - | 145.38M | 295.34M | 240.57M | 327.35M |
| Inventory | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | 782.05M | 1.07B | 1.07B | 1.09B |
| Total Liabilities | - | - | 2.88B | - | 3.97B | 8.35B | 7.95B | 8.02B |
| Current Liabilities | - | - | 1.01B | - | 1.13B | 2.07B | 2.00B | 2.20B |
| Long Term Debt | - | - | 1.11B | - | 2.22B | 4.94B | 4.73B | 4.57B |
| Total Debt | - | - | - | - | 2.22B | 4.94B | 4.74B | 4.64B |
| Total Equity | 1.32B | 1.47B | 2.30B | - | 2.70B | 4.14B | 4.04B | 2.74B |
| Shares Outstanding | - | - | - | - | 52.37M | 67.88M | 68.85M | 70.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 449.74M | 507.61M | 514.18M | 600.72M | 678.01M | 667.49M | 806.97M |
| Investing Cash Flow | -151.01M | -109.22M | -78.65M | -1.84B | -2.11B | -244.27M | -250.38M |
| Financing Cash Flow | -339.64M | -335.22M | -401.87M | 1.24B | 1.80B | -492.53M | -491.44M |
| Capital Expenditure | -111.12M | -171.33M | -149.08M | -140.02M | -180.53M | -238.76M | -234.50M |
| Free Cash Flow | 338.61M | 336.28M | 365.10M | 460.70M | 497.48M | 428.73M | 572.47M |
| Share Buybacks | 0 | 0 | 25.10M | 120.82M | 63.96M | 136.10M | 168.71M |
| Dividends Paid | 0 | 0 | 13.08M | 53.43M | 63.49M | 83.81M | 89.62M |
Ratios (Annual)
Figures in %.
| Metric | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | 37.1% | 35.2% | 35.3% | 35.7% | 36.2% | 35.9% | 35.0% |
| Operating Margin % | 6.3% | 6.5% | 10.2% | 10.1% | 9.3% | 6.2% | -9.3% |
| Net Margin % | 2.5% | 3.5% | 7.3% | 6.9% | 4.4% | 2.6% | -13.0% |
| ROE % | 8.0% | 7.2% | - | 16.1% | 7.6% | 6.2% | -46.6% |
| ROCE % | - | 7.4% | - | 11.6% | 6.3% | 6.0% | -10.7% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CNXC
Currys Turns Nearly Six Million Customer Interactions Into Actionable Insights - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNdVNGcjB5TTJ5WDhiU1JtbW1URjRBb05sZkNkc0czMzV4eHRIMHk3Z3ZZaWZYT2Y4OWxWVTlscjczRTEzNnI1d01DUVJOU2VBQVBlWTRjYzhXLUVTMmI5QmZCNnFRLURCTnRtU2ZLVUg4UEFzNFBYQU9oMGRlRDBpY3hGcXhoQzhKYUNhTD…
Concentrix to Share Enterprise AI Insights at Ai4 2026 in Las Vegas - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQOTRYYVlSbG9lSDM4a1FtSzJiUmQ1aGZEOS11UFM1RTZpQ3NlUFQ4c2N1RjdKM2tPME5yVUNyc0JwZVJFaHBxT1AxYmw4MUtEWHF4b1dsMWhHR050SjM4V2tWSjZRUUVTUHlLMDZZbzRMc2ptSXUzSWdFeFNkN3dmLWRqeF96NnZGaWVDZU…
Concentrix (CNXC) Could Be 30% Undervalued On Ai4 2026 Attention - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPQWwtdGMzdThsQnJ3UEd5bjhyV2I5SU1sQkctWXdFM2I2ay1ETnBSb1NlTmZyc3VzS3p3TVB4cmVwT3B1RUlKbDJuM05zUXNYbmxlMERQU0dRRzJNcFF2RExhZHk4V1hSdm9CNTdxRFR0M21JUnRIVTlzOXFXc1V4bzV1WUZxYlJIVms2d0…
Why Concentrix (CNXC) Shares Are Getting Obliterated Today - StockStory
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOOGNkS2JBNHBXUVg2S1p4T0lES19yQktYbUpOd243dDdXamdyLTR6aEt1cDV2TG5tbzhEMVplSmhFRm42bkp2NFFoYkYxMGtzaHM1THpQYVdsa1htazZLeDJSd1UxR0JDRzN0cXlkYlZDREZIaEZhQzNiX0VmdGRkaDNWWEljV2hZU3JGWV…
Why Concentrix (CNXC) Stock Is Nosediving - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPTld1UWt4VWhpTnI4ZXV5S0tnU2dsbExoa3QxSW5nd0FjbVZkVnNPNVNLTWdBUlRBcnRmWDd2VWpBMXNkNUZTVXdQYVlBeTZER3pBM1NrWUZzeUUzZ043TnhXT3hQck8xME1iM0haQldQaFBsVHhyYUlTcGI0U2VEaXVReE5XX3Jzbi1FYS…
Concentrix Stock Crashes After Q2 Earnings Print — Here's Why - Benzinga
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPYjlTZ1RQV1VDckNZZFV4WHNrTWo2Q0JoU19xS1BjN2x6NElDcHBSQlpDcEw1cmJydHVaT1NlMnJDMFg0YTUxcmFVLWV3Z3QwQURXMFJEdEF2QXZDUnZNZ2N1MDFDZlR6RUNfNC1aWDRPVHRQTFExcW1QYldPRTRDcHE1QlpyT3l6SFllMH…
CNXC — Frequently Asked Questions
What is the current share price of CNXC?
As of 2026-08-05 17:25 PDT, CNXC trades at $26.06 on NASDAQ/NYSE. Its 52-week range is $20.63 to $54.48.
What is the market capitalisation of CNXC?
CNXC has a market capitalisation of $1.83B on NASDAQ/NYSE.
What is the P/E ratio of CNXC?
CNXC trades at a trailing price-to-earnings (P/E) ratio of -1.28. Its price-to-book (P/B) ratio is 0.67.
What is the return on equity (ROE) of CNXC?
CNXC has a return on equity (ROE) of -46.60%. Its return on capital employed (ROCE) is -10.72%.
Is CNXC a good stock to buy?
This page provides a data-driven analysis of CNXC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.